Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALAB vs GSK✓SelectedUSD · GSKALAB vs GSK performance historyLatest closeAs of-8.79%11/16
Stock and ETF performance explorer

ALAB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+226.2%
GSK return
+33.4%
Excess return
+192.8%
Maximum drawdown
-63.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.8%-0.1%-8.7%-8.8%
7D-6.7%-1.3%-5.4%-7.0%
30D-29.2%+2.7%-31.9%-28.6%
3M-37.1%+2.7%-39.8%-36.2%
6M-13.0%+3.3%-16.4%-11.7%
YTD+21.6%+6.5%+15.2%+24.6%
1Y+40.2%+10.7%+29.5%+44.2%
All+226.2%+33.4%+192.8%+288.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling